Back to top

ARS Pharmaceuticals (SPRY) Gains on Japanese Approval for Neffy Nasal Spray

ARS Pharmaceuticals (SPRY) Gains on Japanese Approval for Neffy Nasal Spray

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ARS Pharmaceuticals, Inc. (SPRY)